Author:
Cervantes Francisco,Pereira Arturo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference44 articles.
1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.;Vardiman;Blood,2009
2. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): consensus on terminology by the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT).;Mesa;Leuk Res,2007
3. Genetics of the myeloproliferative neoplasms.;Abdel-Wahab;Curr Opin Hematol,2011
4. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.;Tefferi;Leukemia,2010
5. JAK2 inhibitors: whats the true potential Blood R;Santos;ev,2011
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献